Cannabidiol (CBD) for Post-Traumatic Stress Disorder (PTSD)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Post-Traumatic Stress Disorder (PTSD)+1 MoreCannabidiol (CBD) oral solution - Drug
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether CBD can be safely used alongside exposure therapy to help people with PTSD.

Eligible Conditions
  • Post Traumatic Stress Disorder
  • Post-Traumatic Stress Disorder (PTSD)

Treatment Effectiveness

Study Objectives

2 Primary · 7 Secondary · Reporting Duration: Baseline, Day 4, Day 8, Day 15 and at about 45 Days (1 month follow-up visit)

Month 1
Brief Inventory of Psychosocial Functioning (BIPF)
Clinician Administered PTSD Scale (CAPS-5)
Insomnia Severity Index (ISI)
Veterans Rand 12-Item Heath Survey (VR-12)
Month 1
Depressive Symptoms Index-Suicidality Subscale (DSI-SS)
Generalized Anxiety Disorder Screener (GAD-7)
Patient Health Questionnaire-9 (PHQ-9)
Posttraumatic Cognitions Inventory (PTCI).
Month 1
Posttraumatic Stress Disorder Checklist (PCL-5)

Trial Safety

Trial Design

2 Treatment Groups

Cannabidiol (CBD)
1 of 2
Placebo
1 of 2

Active Control

Non-Treatment Group

28 Total Participants · 2 Treatment Groups

Primary Treatment: Cannabidiol (CBD) · Has Placebo Group · Phase 1 & 2

Cannabidiol (CBD)ActiveComparator Group · 2 Interventions: Cannabidiol (CBD) oral solution, Massed Prolonged Exposure (mPE) · Intervention Types: Drug, Behavioral
PlaceboPlaceboComparator Group · 2 Interventions: Placebo, Massed Prolonged Exposure (mPE) · Intervention Types: Drug, Behavioral

Trial Logistics

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, day 4, day 8, day 15 and at about 45 days (1 month follow-up visit)

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
399 Previous Clinical Trials
73,697 Total Patients Enrolled
Casey Straud, PsyDPrincipal InvestigatorUniversity of Texas Health Science Center San Antonio
1 Previous Clinical Trials
40 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are between the age of 18 and 65 years old.

Who else is applying?

What state do they live in?
Texas100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
University of Texas Health Science Center at San Antonio - STRONG STAR Northwest Center100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%